Scientific Sponsorships & Other Corporate Funding Requests support organizations’ scientific, medical, and educational activities that advance Genmab’s interests in cancer and other serious diseases.
Funder: Genmab
Due Dates: At least 60 days before activity start (requests)
Funding Amounts: No fixed funding amount stated
Summary: Supports scientific sponsorships and corporate activities aligned with Genmab’s interests in cancer and other serious diseases.
Key Information: Requests need a substantive scientific or educational focus and cannot directly benefit Genmab employees.
Genmab supports scientific sponsorships and other corporate funding requests aligned with its vision to transform the lives of people with cancer and other serious diseases. Support may take the form of a corporate sponsorship or membership for an organization’s event or other activity with a primary scientific, medical, or educational purpose. Requests should identify the sponsorship and therapeutic objectives, intended audience, geographic reach, and tangible benefits associated with the support.
Genmab’s interests include hematologic malignancies—large B-cell lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia—and solid tumors, including non-small cell lung, head and neck, endometrial, cervical, and ovarian cancers. Genmab also considers the broader hematologic malignancy and solid tumor areas.